Resumo

RODRIGUEZ CARINO, Hermelinda et al. Risk factors for Infecction by Respiratory Sincitial Virus in Venezuela: Experts meeting. October 2013. Arch Venez Puer Ped [online]. 2016, vol.79, n.2, pp.77-84. ISSN 0004-0649.

Respiratory syncytial virus (RSV) is one of the most common causative agents of respiratory infections in children under 2 years of age. The most common clinical form is bronchiolitis. Within this vulnerable population, infants born before 32 weeks gestation and those with bronchopulmonary dysplasia or with cyanotic congenital heart disease, heart failure or pulmonary hypertension are more susceptible; infants with lung anomalies, neuromuscular diseases, cystic fibrosis or severe immunosuppression are also at risk. RSV causes chronic inflammatory changes that lead to short, medium and long term sequelae. Prevention has proven to be the best measure to reduce complications and costs and palivizumab prophylaxis has been effective in infants at risk. The following article aims to review the risk factors involved in infection by respiratory syncytial virus and establish the criteria for prophylaxis with palivizumab.

Palavras-chave : VSR; prophylaxis; palivizumab.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )